Q开关Nd:YAG激光治疗面部激素依赖性皮炎临床分析.docVIP

  • 5
  • 0
  • 约 8页
  • 2016-08-31 发布于北京
  • 举报

Q开关Nd:YAG激光治疗面部激素依赖性皮炎临床分析.doc

Q开关Nd:YAG激光治疗面部激素依赖性皮炎临床分析.doc

Q开关Nd:YAG激光治疗面部激素依赖性皮炎临床分析   [摘要] 目的 观察Q开关Nd:YAG激光治疗面部激素依赖性皮炎的临床疗效。 方法 将120例患者随机分为两组,对照组予以抗组胺药物、维生素B6口服治疗;治疗组在对照组的基础上加用Q开关Nd:YAG激光照射治疗。结果 治疗组患者瘙痒程度、总积分治疗后均低于对照组,治疗组总有效率为86.67%,对照组总有效率为66.67%,两组比较,差异有统计学意义(P0.05)。 结论 采用大光斑低能量Q开关Nd:YAG激光1064 nm照射治疗面部激素依赖性皮炎安全有效,是一种值得推荐和尝试的方法。   [关键词] 面部激素依赖性皮炎;Q开关Nd:YAG激光;1064 nm   [中图分类号] R758.2 [文献标识码] B [文章编号] 1673-9701(2015)15-0087-03   [Abstract] Objective To observe the clinical curative effect of Q-switch Nd: YAG laser on the treatment of facial hormone-dependent dermatitis. Methods Attal of 120 patients were randomly divided into two groups. The control group was orally administered antihistaminic drugs and Vitamin B6. Based on drugs applied to the control group, additional Q-switch Nd: YAG laser radiation therapy was introduced into the treatment group. Results After the treatment, pruritus and total scores of skin lesion in the treatment group were less than the control group. A total effective rate of 86.67 % was achieved in the treatment group, while that was 66.67 % in the control group. The difference between the two groups was statistical significant(P0.05). Conclusion The treatment of facial hormone-dependent dermatitis with large light-spot and low-energy Q-switch Nd: YAG laser 1064 nm radiation therapy is safe and effective. Therefore, it is well worth popularizing and trying.   [Key words] Facial hormone-dependent dermatitis; Q-switched Nd:YAG laser; 1064nm   面部激素依赖性皮炎(Facial hormone-dependent dermatitis)近年来发病率呈明显上升趋势,目前已是皮肤科较常见疾病。本病例的患者因为自身脸膛皮肤的变薄,导致毛细血管的扩张及面部皮肤屏障功能的受损,每当遇到日光照射、自然风吹、温度变化剧烈及饮食不当(如进食刺激性食物)之后,面部症状就会加重,同时99%的护肤品在此类面部皮肤上几乎无法使用。因此本病患者往往出现不良的情绪,多见烦躁、焦虑及悲观,同时对社交活动都不愿出席,对学习、工作及生活的影响具有严重性,已越来越引起皮肤科医师的重视[1]。笔者在临床中尝试应用大光斑低能量Q开关Nd:YAG激光1064 nm照射治疗面部激素依赖性皮炎,效果较好,现报道如下。   1 资料与方法   1.1 一般资料   选择我院2013年1月~2014年12月间的皮肤科门诊患者120例,分为治疗组和对照组各60例。其中治疗组女37例,男23例,年龄19~49岁,平均(32.3±1.5)岁;激素用药时间2个月~3年,平均(6.5±2.1)个月;对照组女39例,男21例,年龄23~50岁,平均(34.1±2.3)岁;激素用药时间3个月~4年,平均(5.5±1.7)个月。两组病例临床资料等方面均无显著差异,具有可比性。   1.2 纳入标

文档评论(0)

1亿VIP精品文档

相关文档